Multiomics 2023

Applying multiomics to novel target discovery in immuno-oncology

Immuno-Oncology Insights 2023; 4(6), 249–255


Published: 9 August 2023
Eran Ophir, Yaron Turpaz

Róisin McGuigan, Editor, Immuno-Oncology Insightsspeaks with (pictured from left to right) Eran Ophir, Chief Scientific Officer, Compugen, and Yaron Turpaz, Senior Vice President and Senior Advisor, Data and Informatics Solutions, Compugen, about the advantages of using multi-omic and computational approaches for the discovery of novel targets and mechanisms of action of novel drug candidates in immuno-oncology.